Drugplain

Oraverse .235 mg/mL

Phentolamine Mesylate · INJECTION, SOLUTION · Septodont, Inc.

No Recall History
Plain English

Oraverse is a injection, solution containing phentolamine mesylate at .235 mg/mL, taken submucosal. Manufactured by Septodont, Inc..

Key Facts

Brand Name
Oraverse
Generic Name
Phentolamine Mesylate
NDC Code (Product)
0362-0101
Manufacturer
Septodont, Inc.
Strength
.235 mg/mL
Dosage Form
INJECTION, SOLUTION
Route
SUBMUCOSAL
Marketing Status
Application #
NDA022159
Marketing Start
06/01/2011

Recall History

No Recall History

Frequently Asked Questions

What is Oraverse used for?

Oraverse contains Phentolamine Mesylate. It is a injection, solution taken submucosal. Consult your doctor for specific uses.

Is Oraverse a controlled substance?

Oraverse is not classified as a controlled substance by the DEA.

What is the generic name for Oraverse?

The generic name for Oraverse is Phentolamine Mesylate. There are 3 other brand versions of Phentolamine Mesylate.

What is the NDC code for Oraverse .235 mg/mL?

The NDC (National Drug Code) for Oraverse .235 mg/mL is 0362-0101, listed by Septodont, Inc..

Product NDC

0362-0101

Package NDC

0362-0101-10

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)